John C. Pottage, Jr., M.D. served as Senior Vice President and Chief Scientific and Medical Officer of ViiV Healthcare from November 2009 to October 2019, where he oversaw research and development, regulatory, safety and medical affairs. Prior to joining ViiV Healthcare, Dr. Pottage served as Senior Vice President and Head of the Infectious Disease Medicine Development Center at GlaxoSmithKline from September 2008 to November 2009, and prior to that, from June 2007 to September 2008, as Vice President of Global Clinical Development of Antivirals at GlaxoSmithKline. Prior to GlaxoSmithKline, Dr. Pottage held several positions of increasing responsibility at Achillion Pharmaceuticals and Vertex Pharmaceuticals. Before joining the Biotechnology/Pharmaceutical industry, Dr. Pottage held various clinical and academic positions at Rush University Medical Center in Chicago, IL. Dr. Pottage currently is a non-executive Director of Spero Therapeutics in Cambridge, MA. He received his A.B. in biology from Colgate University and his M.D. from Saint Louis University School of Medicine. He is Board certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine.